DocDollars

Ascendis Pharma Endocrinology Inc

CA · United States · Reporting entity ID 100000941823

Total reported 2019–2025
$22.9M
#291 of 2,960 reporting companies — 0% of all reported industry payments
$4.78M in general payments across 20,931 records, plus $18.2M in research funding across 5,386 records.

How it breaks down

General payments $4,784,129
Research funding $18,154,305

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ascendis Pharma Endocrinology Inc reported $22.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #291 of 2,960 reporting companies. 79% of that was research funding and 21% general payments such as consulting, speaking, food and travel. 20,931 general payment records and 5,386 research records were filed.

Common questions about Ascendis Pharma Endocrinology Inc

How much has Ascendis Pharma Endocrinology Inc paid US doctors?

Ascendis Pharma Endocrinology Inc reported $22,938,434 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,784,129 in general payments, $18,154,305 in research funding.

How does Ascendis Pharma Endocrinology Inc rank among drug and device companies?

It ranks #291 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Ascendis Pharma Endocrinology Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.